Page updated 27 May 2013
Round Table sessions will be held on Thursday 13 June and Friday 14 June 2013 - 07:15-08:15
Category | 13 June 2013 | 14 June 2013 |
Basic Science | pH regulation in CF Leader: Ursula Seidler |
Neutrophils in CF Leader: Dominik Hartl |
MicroRNA in CF Leader: Catherine Greene |
CFTR interactome Leader: Carlos Farinha |
|
Mechanisms of Lung remodelling in CF Leader: Bob Scholte |
||
Clinical Trials/New Therapies | Lung Clearance Index Leader: Anders Lindblad |
Gene Therapy Leader: Jane Davies |
CFTR Modulators Leader: Luis Galietta |
CT as an Outcome Measure Leader: Harm Tiddens |
|
Oral Contraceptives in CF: Pros and cons Leader: Gerry McElvaney |
||
Microbiology/Antibiotics | Host Pathogen Interaction using Genomics Leader: Miguel Valvano |
New Diagnostics (Genomic and Proteomic) Leader: Sally Pattison |
Viruses in CF Leader: William Flight |
Fungi in CF Leader: Sanjay Chotirmall |
|
Bacterial genomics in CF Leader: Geraint Rogers |
Treating B cepacia complex Leader: Alex Horsley |
|
Nursing/Psychosocial Issues | E-health in Practice Leader: Marit van Oirschot |
Supporting Families around Newborn Screening Leader: Pavla Hodkova |
Caring for Carers: Compassion Satisfaction versus Compassion Fatigue Leader: Araxie Matossian |
||
Hygiene & Infection Control Leader: Ellen Julie Hunstad |
||
Physiotherapy | Exercise for the Pre-and Post-Transplant Patient Leader: Paul Burnham |
Assessing Physical Activity Leader: Pierre-Régis Burgel |
Pregnancy in CF - Implications for Physiotherapy Leader: Gemma Stanford |
Intrapulmonary percussive ventilation Leader: Fred Lessire |
|
Pulmonology/Immunology | Stens, Achromo and others: What should we use to treat? Leader: Marianne Skov |
Clinical delivery of nebulised therapies for airway clearance and exercise Leader: Mark Elkins |
Inhaled Mucolytic Drugs in Young Children with CF Leader: Harm Tiddens |
Management of beta-lactam Antibiotic Allergy in the CF Patients Leader: Daniel Peckham |
|
Non classical CF: Diagnostic Pathways (to be conducted in Spanish) Leader: Carlos Vazquez |
Cycling Inhaled Antibiotics in CF Patients: Norm or exception? Leader: Giovanni Taccetti |
|
Genetics/Screening/Diagnosis | Is CF a Clinical or a Genetic Diagnosis? Leader: Peter Durie |
First Experiences with CFTR2 Leader: Manfred Ballmann |
How to Establish Newborn Screening for CF in your country Leader: Kevin Southern |
||
Registry/Epidemiology | Lung Transplanted Patients - which registries can we use? Leader: Lieven Dupont |
Cooperation Between National/International Registries Leader: Bruce Marshall |
Issues in Benchmarking Using Registries Leader: Vincent Gulmans |
Pharmacovigillance in CF Registries Leader: Elaine Gunn |
|
GI/Nutrition/Liver Disease/ Metabolic Complications |
Metabolic Complications in the Ageing Patient Leader: Michael Parkins |
CF Bone Disease: When to use bisphosphonates? Leader: Isabelle Sermet |
Abdominal Complaints in CF: When to do What? Leader: Michael Wilschanski |
Tips and Tricks for Enzyme Suppletion Leader: Drucy Borowitz |
|
The Growth Curve: When to do What? Leader: Helen McCabe |